AEROPERL® 300 Pharma
- INCI/Chemical Name:
- Silicon Dioxide, chemically prepared Ph.Eur USP-NF
- SKU:
- BP124302
Download data
Didn't find the right document?
Request a document
Available packs
AEROPERL® 300 Pharma is mesoporous silica obtained by granulating colloidal silicon dioxide. The main difference between traditional silica and mesoporous silica is that mesoporous silica exhibits a highly ordered internal pore structure. Other than this, it's chemically identical to standard colloidal silicon dioxide.
Features
Granulated form of colloidal silicon dioxide
Spherical granules with a diameter of approximately 30 - 50 μm
Higher tapped density of about 280 g/l compared to the non- granulated products
Pore volume of 1.6 - 1.9 ml/g
Moisture desiccant
Benefits
Mesoporous and unique properties, including ordered pore structures and high internal surface area
High absorption capacity for liquids
Spherical, granular and free-flowing powder which is dust-free
Specific surface area 260 - 320 m2/g
Applications
For improving the bioavailability of poorly water-soluble drug substances (BCS II and IV) by increasing the effective surface area in contact with the dissolution medium
AEROPERL® 300 Pharma can be used to change lipid formulations into powders
Enzyme encapsulation and immobilization to enhance stability, ease recovery and re-use
AEROPERL® 300 Pharma offers an innovative approach to wet granulation processing owing to its ability to efficiently bind moisture while maintaining a stable, functional dry granular powder